Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
  1. Home
  3. Genomic Landscape Defines Peritoneal Metastatic Pattern And Related Target Of Peritoneal Metastasis In Colorectal Cancer.
  1. Home
  3. Genomic Landscape Defines Peritoneal Metastatic Pattern And Related Target Of Peritoneal Metastasis In Colorectal Cancer.

Related Experiment Video

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K

Genomic landscape defines peritoneal metastatic pattern and related target of peritoneal metastasis in colorectal

Minhui Hu1, Rui Luo2, Keli Yang2

  • 1Department of Gastrointestinal Endoscopy, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

International Journal of Cancer
|May 13, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study developed a colorectal cancer peritoneal metastasis prediction model using genomic and clinicopathological data. SERINC1 was identified as a potential therapeutic target to suppress cancer spread.

Keywords:
SERINC1colorectal cancer peritoneal metastasisgenomic landscapegenomic signature

More Related Videos

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
11:43

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones

Published on: November 30, 2016

12.7K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.7K

Related Experiment Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.1K
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
11:43

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones

Published on: November 30, 2016

12.7K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.7K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Peritoneal metastasis (PM) is a significant challenge in colorectal cancer (CRC) treatment.
  • Understanding the genomic drivers of PM is crucial for developing targeted therapies.

Purpose of the Study:

  • To develop a predictive model for PM in CRC by integrating genomic and clinicopathological features.
  • To identify novel therapeutic targets for PM through bioinformatics and experimental validation.

Main Methods:

  • Analysis of genomic and clinicopathological data from 363 CRC patients.
  • Development of a PM prediction model using LASSO regression.
  • Bioinformatic analysis and experimental validation of potential therapeutic targets.

Main Results:

  • An integrated prediction model incorporating clinicopathological and genomic variables demonstrated high accuracy (AUC 0.899) for PM prediction.
  • A peritoneal metastasis-related genomic signature (PGS) showed prognostic stratification capability.
  • SERINC1 was identified as a key gene in PM, and its knockdown suppressed peritoneal dissemination.

Conclusions:

  • The genomic landscape of primary CRC influences its metastatic pattern.
  • SERINC1 is a potential therapeutic target for inhibiting colorectal cancer peritoneal metastasis.